How to Buy Glycomimetics Stock
Glycomimetics Inc
GlycoMimetics, Inc. , a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States.
Glycomimetics stock last closed at $1.71, down 7.82% from the previous day, and has increased 24.82% in one year. It has overperformed other stocks in the Biotechnology industry by 0.48 percentage points. Glycomimetics stock is currently +54.05% from its 52-week low of $1.11, and -51.56% from its 52-week high of $3.53.
At the moment, there are 64.45M GLYC shares outstanding. The market capitalization of GLYC is $110.21M. In the past 24 hours, 546,135 GLYC shares were traded.
How to Buy Glycomimetics Stock
Wondering how to invest in Glycomimetics stock? Here's how.
- Choose where to buy Glycomimetics stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Glycomimetics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Select your payment method and add your information.
- Research Glycomimetics stock: The Glycomimetics ticker symbol is GLYC. Is Glycomimetics stock a good investment? Should you buy shares of GLYC? How do GLYC's underlying business fundamentals look? Do top analysts think Glycomimetics is a good buy? Why has GLYC's stock price moved recently? (Hint: Our stock analysis website can help you understand if GLYC is a good stock to buy).
- Place your GLYC buy order: Decide if you will purchase GLYC shares at the current market price or use a limit order to buy GLYC stock at a particular price.
- Get the latest scoop on your investment in GLYC: Create a watchlist to get live updates on your new investment in Glycomimetics shares.
Step 1: Choose where to buy Glycomimetics stock
You will need an online brokerage account to access the NASDAQ market and buy GLYC shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you are able to buy GLYC stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open your new brokerage account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have filled out your info on one of the best stock apps, your next step is to transfer the money for your investment:
Check out this video walkthrough if you need help transferring funds into your new investment account.
Step 4: Research Glycomimetics stock
After you have chosen the best place to buy Glycomimetics stock, it's very important to evaluate their stock prior to investing, so you actually wrap your head around the risk and opportunity.
Glycomimetics stock quick numbers
Glycomimetics Due Diligence Checks
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on GLYC's stock page.
Is GLYC stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge GLYC's true value.
Using relative valuations methods:
- GLYC could be undervalued based on its P/B ratio of 2.87x, relative to Biotechnology industry P/B ratio of 5.8x
You can do additional valuation analysis on GLYC's stock here.
A quick look at GLYC Financials
Passed Financial Due Diligence Checks:
- GLYC has a low debt to equity ratio of 0.18.
- There are more short-term assets than short-term liabilities on the GLYC balance sheet.
- There are more short-term assets than long-term liabilities on the GLYC balance sheet.
- GLYC has cash burn of 34901297. It has enough cash and short-term investments to cover this for at least one year.
- GLYC has $41.79M in cash and short term investments. This is enough to cover its annual cash burn of $34.90M.
Failed Financial Due Diligence Checks:
- Total GLYC debt is higher than 5 years ago, relative to shareholder equity.
- GLYC profit margin has gone down from -62,251.7% to -368,994.2% in the past year.
Do Wall Street analysts think it's a good time to buy GLYC stock
Out of 2 sell side analysts who track GLYC, the consensus analyst rating on GLYC is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Glycomimetics stock forecast page.
GLYC Technicals
GLYC Growth Metrics
Last year, GLYC revenue was $10.00k. Over the past 3 year, GLYC's revenue has gone up by -99.97% per year. This was slower than the Biotechnology industry average of 28.62%.
Learn more about GLYC's earnings and revenue performance here.
What are GLYC insiders up to?
In the past 12 months, executives and large shareholders at GLYC have bought more shares than they have sold.
Mark Alan Goldberg, Director of GLYC, was the latest GLYC insider to buy. They bought $13,752.00 worth of GLYC shares on Mar 29, 2024.
Get more info about who owns GLYC shares here.
Can I get consistent income from GLYC stock?
No, Glycomimetics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your GLYC buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and eToro will place your order.
If you want additional help buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your investment in GLYC
Now that you own some GLYC shares, you'll want to keep up with your new investment.
Add GLYC to a watchlist to track your GLYC stock.
GLYC Feed
How to Buy Stock in Glycomimetics
To summarize, here are the 6 steps for buying Glycomimetics stock:
- Choose where to buy Glycomimetics stock
- Open your brokerage account
- Deposit money your brokerage account
- Research Glycomimetics stock
- Place your GLYC buy order
- Get the latest scoop on your investment in GLYC
If you require a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to watch your new investment in Glycomimetics, hit the button below to create your watchlist.
More Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.